Lensar (LNSR) Capital Expenditures (2019 - 2025)
Lensar's (LNSR) quarterly Capital Expenditures came in at $77000.0 in Q2 2025, up 185.19% year-on-year from $27000.0 in Q2 2024, and up 1183.33% on a QoQ basis from $6000.0 in Q1 2025.
Lensar (LNSR) Capital Expenditures (2019 - 2025) Analysis & Trends
Lensar (LNSR) has 7 years of Capital Expenditures data on file, last reported at $77000.0 in Q2 2025.
- On a quarterly basis, Capital Expenditures rose 185.19% year-over-year to $77000.0 in Q2 2025; TTM through Dec 2025 was $83000.0, a 46.79% decrease from a year earlier, with the FY2025 full-year figure at $83000.0, down 46.79% from the prior year.
- Capital Expenditures for Q2 2025 stood at $77000.0, up from $6000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for LNSR reached as high as $181000.0 in Q2 2023 and fell as low as -$63000.0 in Q2 2021.
- Historically, Capital Expenditures has averaged $52444.4 across 5 years, with a median of $36000.0 in 2023.
- On a YoY basis, Capital Expenditures climbed as much as 2350.0% in 2021 and fell as far as 141.45% in 2021.
- Year by year, Capital Expenditures stood at $156000.0 in 2021, then tumbled by 63.46% to $57000.0 in 2022, then slipped by 21.05% to $45000.0 in 2023, then plunged by 93.33% to $3000.0 in 2024, then soared by 2466.67% to $77000.0 in 2025.
- Per Business Quant data, the three most recent Capital Expenditures figures were $77000.0 in Q2 2025, $6000.0 in Q1 2025, and $3000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 77,000.00 |
| Jun 30, 2025 | 77,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Jun 30, 2024 | 27,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 181,000.00 |
| Jun 30, 2023 | 181,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Mar 31, 2023 | 8,000.00 |